Zealand Pharma announces publication of Phase 3 trial evaluating efficacy and safety of dasiglucagon for treatment of severe hypoglycemia in adult patients with diabetes

https://www.globenewswire.com/news-release/2021/05/03/2221311/0/en/Zealand-Pharma-announces-publication-of-Phase-3-trial-evaluating-efficacy-and-safety-of-dasiglucagon-for-treatment-of-severe-hypoglycemia-in-adult-patients-with-diabetes.html

press release